查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853838

医药玻璃包装市场：按容器类型、玻璃类型、最终用途、封盖类型和分销管道划分－2025-2032年全球预测

Pharmaceutical Glass Packaging Market by Container Type, Glass Type, End Use, Closure Type, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，医药玻璃包装市场规模将成长 482 亿美元，复合年增长率为 10.94%。

主要市场统计数据
基准年 2024 209.9亿美元
预计年份：2025年 233.1亿美元
预测年份：2032年 482亿美元
复合年增长率 (%) 10.94%

从策略层面了解影响医药玻璃包装的技术、监管和供应链动态，从而引导可执行的决策。

医药玻璃包装面临严格的法律规范、不断发展的药物剂型以及日益复杂的供应链的多重挑战。过去十年，治疗产品组合的变化，特别是生技药品和注射剂的兴起，推动了对包装形式的需求，这些包装形式优先考虑容器的完整性、可萃取/可浸出特性以及低温运输相容性。同时，永续性的期望和循环经济的目标正在重塑整个价值链的材料选择和采购标准。

因此，从配料商和契约製造製造商到采购团队和监管机构，相关人员必须清晰地整合影响包装决策的技术、商业性和地缘政治因素。本出版物概述了影响材料选择、封盖相互作用和分销限制的关键因素，为后续分析组装了策略背景。随着监管审查力度加大和产品复杂性增加，务实地进行供应商资格确认、品质工程和风险缓解对于商业性成功至关重要。

以下章节将揭示产业格局的变革性转变，深入探讨近期美国关税措施在2025年的累积影响，并提供切实可行的细分和区域洞察，以帮助产业领导者确定投资和营运调整的优先顺序。过渡性说明将技术要务与商业性成果连结起来，使决策者能够将洞察转化为短期和中期行动。

药物剂型演变、监管审查、供应链多元化和永续性措施如何重塑药品玻璃包装策略

随着药物剂型创新、监管要求不断提高以及对永续性的承诺，医药玻璃包装产业正经历一场变革，这要求材料科学和供应链韧性达到更高水准。生技药品和复杂的注射剂对容器密封系统提出了更高的要求，加速了对更高等级硼硅酸配方、先进的瓶塞化学技术以及增强型表面处理的需求，这些技术能够减少分层并保持药物相容性。同时，製造商也在投资分析能力，以便更好地表征产品生命週期中的萃取物和浸出物。

供应链策略也在不断演变。企业正在实现供应商多元化，并对多个区域供应商进行认证，以规避地缘政治和关税风险；同时，企业也与玻璃製造商和瓶盖供应商建立更深入的战略伙伴关係，以确保优先配额并共同製定产品规格。数位化进一步强化了这种向供应商合作的转变，可追溯性平台和智慧标籤提高了批次层级的可视性，并在必要时能够更快地进行召回和隔离。

永续性已从声誉考量转变为营运重点，推动了对再生材料、节能玻璃製造和循环物流的投资。因此，采购和研发团队正在权衡上游製程排放、报废管道和材料替代等因素，同时兼顾技术性能标准。这些变革性动态共同要求制定整体策略，协调研发、品质、采购和监管职能，以在优化成本和提升韧性的同时，维持产品完整性。

分析2025年美国关税对医药玻璃包装采购经济性、供应商合格及战略供应链韧性的累积影响

2025年美国关税的实施对整个医药玻璃包装生态系统的筹资策略、供应商经济状况和商业谈判都产生了累积影响。对于先前依赖跨境供应高品质玻璃管、玻璃容器和特殊瓶盖的製造商而言，进口成本的上涨立即促使他们重新审视到岸成本的计算方法和合约条款。为此，采购团队正在加快推进国内及关联国家工厂的供应商资格认证计划，以降低关税造成的价格波动风险。

除了直接的成本压力外，关税还促使企业进行更广泛的营运改革。各公司重新审视了库存管理方式和安全存量基准，以平衡持有大量陆基库存增加的成本与关税相关中断再次发生的风险。此外，资本配置也转向支持双重采购计划，与区域玻璃製造商签订长期承购协议，并在条件允许的情况下投资本地加工能力。这些措施旨在缩短前置作业时间，并保护关键项目免受成本突然增加的影响。

从监管和合规的角度来看，对替代供应商进行资格合格需要品质、监管和供应链团队之间的跨职能协作，以确保新供应商满足既定的化学品和颗粒物规格，同时避免引入不必要的专案风险。 2025 年的关税环境进一步凸显了整合筹资策略的重要性，该策略应将成本控制与技术合格、营运弹性以及买卖双方共用担风险的合约机制相结合。

透过对容器类型、玻璃分类、治疗用途、封盖技术和分销管道进行深度細項分析，可以做出切实可行的包装决策。

一个完善的细分框架揭示了产品形态、材料成分、最终用途、瓶盖设计和分销管道如何共同影响医药玻璃包装的技术要求和商业性优先级。容器类型决定了关键性能指标：安瓿瓶适用于单剂量应用，可最大限度减少污染；而瓶子则用于口服液和外用药物，其首要考虑的是惰性和与给药机制的兼容性。

玻璃类型进一步影响决策，I 型玻璃通常因其优异的耐水解性而成为高稳定性生技药品的首选，但当加工经济性和特定监管渠道允许时，也可选用于 II 型和 III 型玻璃。生物技术产品、注射剂、眼科产品、口服製剂和疫苗等最终用途类别具有独特的监管和功能限制，这些限制与容器和密封件的选择、灭菌方法以及可萃取物/可浸出物测试制度相关。压盖可为注射剂小瓶提供可靠的无菌保证，橡胶塞可提供必要的管瓶，溴丁基橡胶和氯丁基橡胶等不同材质因其弹性体相容性和渗透性而被选用，而螺旋盖和卡扣盖则适用于口服和外用製剂，因为这些製剂对可重复密封性和用户工程学要求较高。

分销管道也影响包装的优先考虑因素：医院药房需要坚固耐用的包装，以适应高容量、无菌操作环境；线上药房管道优先考虑安全、防篡改的解决方案以及在分销过程中的环境稳定性；而零售药房则必须在货架吸引力、耐用性和易取用性之间取得平衡。整合这些细分因素，可以更细緻地了解产品规格、供应商能力和品管措施，从而确定特定玻璃瓶和瓶盖组合是否适用于每种治疗方法和分销情况。

美洲、欧洲、中东和非洲以及亚太地区面临的战略挑战，推动了采购、合规和产能扩张的优先事项。

在整个医药玻璃包装价值链中，区域动态持续对采购、监管协调和产能扩张决策产生决定性影响。在美洲，製造商受益于接近性大型医药中心以及对监管合规的重视（优先考虑快速资格确认） ，但同时也面临着本地化供应和降低关税的压力。这促使他们投资建立本土化改造能力并加强与供应商的伙伴关係，以确保高价值生技药品计画的持续性。

欧洲、中东和非洲呈现出多元化的格局，先进的玻璃製造能力与不断变化的监管环境并存。欧洲生产商往往在低碱硼硼硅酸和节能炉技术的创新方面处于领先地位，而该地区的法规结构则强调对可萃取物和可浸出物进行严格的评估，从而推动供应商儘早参与并提交详尽的文件。同时，中东和非洲市场作为分销中心和区域製造扩张的潜在地点，其重要性日益凸显，以满足不断增长的当地需求。

亚太地区仍然是玻璃原液生产和加工的重要中心，该地区的製造商正在扩大产能以满足全球供应链的需求。该地区的製造业深度和成本竞争力使其成为重要的策略供应来源，但对品质的要求和监管的协调一致要求企业持续发展供应商并建立健全的审核机制。由于产能、监管要求和地缘政治因素在任何特定地区都相互作用，企业必须制定差异化的区域策略，将在地采购与有效的全球支持相结合。

一家领先供应商如何将高纯度玻璃技术、整合品质系统、策略性收购和合作伙伴关係相结合，以满足不断变化的製药需求

主要企业透过投资高纯度玻璃配方、整合品质系统以及拓展贸易以外的伙伴关係关係来脱颖而出。具有策略眼光的公司正采用先进的分析技术来监控生产的一致性，利用线上检测技术来降低缺陷率，并投资低排放炉技术，以实现营运效率和永续性目标。同时，一些供应商正在拓展其服务范围，例如提供法规文件协助、开展稳定性测试合作以及与药物研发商共同开发契约，以加快产品上市速度并降低新型容器密封结构带来的风险。

竞争动态也反映出某些细分领域的整合趋势，大型製造商透过扩大产能或进行策略性收购来扩大在管瓶和预填充式注射器等高需求剂型中的规模。同时，灵活的专业供应商则专注于利基技术，例如高性能密封配方或针对特定技术故障模式的先进玻璃涂层。由此导致供应商出现两极化，规模和专业化并存，迫使製药公司采取以技术相容性、产能可靠性和长期创新蓝图图为驱动的先进供应商细分策略。

最后，随着企业寻求在实际条件下检验整合容器密封系统，设备製造商、弹性体製造商和分析实验室之间的跨产业合作日益普遍。此类伙伴关係能够缩短资格确认週期，并提高产品在上市时以及整个生命週期各个阶段的效能可预测性。

为製造商提供切实可行的、可复製的措施，以增强供应商多样性、检验容器密封性能，并在不损害产品完整性的前提下融入永续性。

产业领导者应采取多管齐下的方法，将技术检验、采购弹性和永续性性相结合，以在保持商业性灵活性的同时保障产品完整性。这首先要针对关键产品形式和材料实施双重筹资策略，并建立快速供应商资格确认管道，重点关注可萃取物和可萃取物的分析可比性、容器密封完整性和颗粒物特征。这些措施可以减少单一供应商带来的损失，并为应对地缘政治或关税相关干扰提供营运方案。

同时，生命週期概念应融入包装决策，评估在符合回收性、炉能耗和药品稳定性要求的前提下，尽可能采用再生玻璃屑。过渡计画应分阶段进行稳定性和相容性研究检验，以避免意外的品质风险。此外，应优先考虑与能够提供联合开发能力、法规文件协助以及与双方商定的绩效指标挂钩的产能扩张承诺的供应商建立长期伙伴关係。

在营运方面，我们投资先进的测试和追溯系统，以加强批次级控制，并在出现偏差时加快根本原因分析。我们儘早让跨职能团队参与容器和封盖的选择，以确保配方科学家、品质、供应链和法规部门在测试方案和验收标准方面保持一致。最后，我们持续进行动态情境规划，模拟关税变化、原材料短缺和需求激增等情况，使领导者能够及时做出基于事实的决策，从而在技术完整性和商业性需求之间取得平衡。

一种透明且有效的调查方法，结合专家访谈、法规和技术文献研究以及三角验证，为可操作的包装情报提供支援。

本分析的调查方法结合了定性和定量证据，以得出可靠且有理有据的结论和建议。主要资讯收集工作包括对来自製造商、合约包装商和供应商公司的包装工程师、采购负责人、法规事务专业人员和品质保证专家进行结构化访谈，以获取有关技术挑战、采购动态和战略应对措施的第一手观点。这些访谈旨在揭示细分和区域分析所需的营运限制、供应商选择标准和检验方法。

二次研究包括对监管指导文件、行业技术标准、关于玻璃配方和瓶盖相互作用的白皮书以及近期发表的关于可萃取物/可浸出物、分层和容器密封完整性测试的同行评审文献的全面审查。这些背景资料为比较评估提供了最佳实践框架和技术基准。数据检验透过三角测量法实现。访谈中发现的论点和趋势与已记录的监管立场以及供应商和行业联盟披露的生产能力资讯进行了交叉核对。

本调查方法的局限性包括关税政策的不断演变（可能快速变化）以及供应商在专有配方和工艺规范披露方面的差异。为弥补这些局限性，我们纳入了敏感度分析和情境分析，并精心挑选受访者，以确保其在地域、公司规模和职能角色方面的多样性。最终形成的调查方法兼顾了深刻的洞察和实际检验，可为策略决策提供支援。

协调技术检验、供应商韧性和永续性以保障药品品质和商业性灵活性的关键要点

总之，医药玻璃包装正处于策略曲折点，技术要求、监管严格程度和供应链动态正在交汇融合，重塑采购和开发选择。复杂生技药品和注射疗法的兴起，凸显了材料选择、密封化学和容器密封完整性的重要性，因此需要更早地进行跨职能协作和供应商参与。同时，关税波动和地缘政治格局的变化正在加速区域化和双重采购模式的形成，迫使企业重新思考库存策略和资格认证管道。

如今，永续性和营运效率与采购和研发决策直接相关，推动企业投资低排放气体生产、在适当情况下使用再生材料以及循环物流。为了应对这项挑战，企业必须将严谨的技术检验与策略性的供应链多元化相结合，投资于数位化可追溯性和检测能力，并建立支持协同开发和监管环境的长期伙伴关係关係。这些努力的结合将使製药企业和供应商能够在日益复杂的全球环境中，在保障产品品质的同时，保持商业性灵活性和合规性。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 琥珀色管瓶越来越多地被用于提高生物药品在紫外光下的稳定性。
  • 增强预填充玻璃注射器的应用，以提高生技药品製剂给药的剂量准确性和安全性
  • 过渡到使用 I 型硼硅酸玻璃容器，以满足注射药物严格的监管要求。
  • 增加对先进玻璃涂层技术的投资，以降低颗粒污染的风险
  • 用于疫苗储存的内置微生物屏障的多剂量管瓶的需求激增
  • 采用在玻璃容器中嵌入RFID感测器的智慧包装解决方案，实现药品即时追踪
  • 开发薄壁玻璃墨盒，以优化注射包装的材料利用率并最大限度地减少碳排放
  • 扩大回收和玻璃重熔倡议，以支持永续的药品包装实践

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依容器类型分類的医药玻璃包装市场

  • 安瓿
  • 瓶子
    • 口服液
    • 局部的
  • 墨水匣
    • 安全
    • 标准
  • 预填充式注射器
  • 管瓶
    • 多次给药
    • 单一剂量

9. 依玻璃类型分類的医药玻璃包装市场

  • 一型
  • II 型
  • III型

10. 依最终用途分類的医药玻璃包装市场

  • 生物技术产品
  • 注射药物
  • 眼科产品
  • 口服药物
  • 疫苗

11. 以瓶盖类型分類的医药玻璃包装市场

  • 压盖
  • 橡胶帽
    • 溴丁基
    • 氯丁基
  • 螺帽
  • 卡扣式帽

第十二章 按分销管道分類的医药玻璃包装市场

  • 医院药房
  • 网路药房
  • 零售药房

13. 各地区医药玻璃包装市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 依组别分類的医药玻璃包装市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：各国医药玻璃包装市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Gerresheimer AG
    • SGD Pharma SA
    • SCHOTT AG
    • Stevanato Group SpA
    • Nipro Corporation
    • Ardagh Group SA
    • Owens-Illinois, Inc.
    • Piramal Glass Limited
    • Temco Group Ltd.
    • Universal Glass Packaging, Inc.
Product Code: MRR-02026C4CAEBB

The Pharmaceutical Glass Packaging Market is projected to grow by USD 48.20 billion at a CAGR of 10.94% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 20.99 billion
Estimated Year [2025] USD 23.31 billion
Forecast Year [2032] USD 48.20 billion
CAGR (%) 10.94%

A strategic framing of technical, regulatory, and supply chain dynamics influencing pharmaceutical glass packaging that guides actionable decisions

The pharmaceutical glass packaging arena sits at the intersection of stringent regulatory oversight, evolving drug modalities, and intensifying supply chain complexity. Over the last decade, shifts in therapeutic portfolios, especially the rise of biologics and injectable therapies, have amplified demand for packaging formats that prioritize container integrity, extractable and leachable profiles, and cold chain compatibility. At the same time, sustainability expectations and circularity ambitions are reshaping material choices and procurement criteria across the value chain.

Consequently, stakeholders-from formulators and contract manufacturers to procurement teams and regulatory affairs groups-require a clear synthesis of technical, commercial, and geopolitical influences that affect packaging decisions. This introduction frames the strategic context for the subsequent analysis by outlining the primary drivers shaping material selection, closure interactions, and distribution constraints. As regulatory scrutiny tightens and product complexity increases, pragmatic approaches to supplier qualification, quality engineering, and risk mitigation become central to commercial success.

The following sections unpack transformative shifts in the landscape, delve into the cumulative impact of recent tariff actions originating in the United States during 2025, and provide actionable segmentation and regional insights that will help industry leaders prioritize investments and operational adjustments. Transitional commentary will connect technical imperatives to commercial consequences so that decision-makers can translate insight into immediate and mid-term actions.

How evolving drug modalities, regulatory scrutiny, supply chain diversification, and sustainability commitments are reshaping pharmaceutical glass packaging strategies

The pharmaceutical glass packaging landscape is undergoing a set of transformative shifts driven by innovation in drug modalities, heightened regulatory expectations, and sustainability commitments that together demand new levels of material science and supply chain resilience. Biologics and complex injectables are placing premium requirements on container closure systems, which in turn has accelerated demand for higher-grade borosilicate formulations, advanced stopper chemistries, and enhanced surface treatments that reduce delamination and maintain drug compatibility. Concurrently, manufacturers are investing in analytical capabilities to better characterize extractables and leachables across product lifecycles.

Supply chain strategies are also evolving: companies are diversifying supplier bases and qualifying multiple regional sources to hedge geopolitical risk and tariff exposure, and they are establishing deeper strategic partnerships with glassmakers and closure suppliers to secure priority allocations and co-develop specifications. This shift toward collaborative supplier relationships is reinforced by digitalization, where traceability platforms and smart tagging improve lot-level visibility and expedite recalls or quarantines when necessary.

Sustainability has moved from a reputational consideration to an operational priority, prompting investments in recycled content, energy-efficient glass production, and circular logistics. As a result, procurement and R&D teams increasingly evaluate upstream emissions, end-of-life pathways, and material substitution trade-offs in tandem with technical performance criteria. Taken together, these transformative dynamics require holistic strategies that align R&D, quality, procurement, and regulatory functions to maintain product integrity while optimizing cost and resilience.

Analysis of the cumulative effects of United States tariff actions in 2025 on sourcing economics, supplier qualification, and strategic supply chain resilience across pharmaceutical glass packaging

Tariff actions originating in the United States during 2025 have had a cumulative effect on sourcing strategies, supplier economics, and commercial negotiations across the pharmaceutical glass packaging ecosystem. For manufacturers that historically relied on cross-border supplies for high-quality tubing, primary glass containers, and specialized closures, increased import costs have prompted immediate reassessment of landed cost calculations and contract terms. In response, procurement teams have accelerated supplier qualification programs in domestic and allied-country facilities to reduce exposure to tariff-driven price volatility.

Beyond direct cost pressure, tariffs have catalyzed broader operational changes. Organizations have revisited inventory policies and safety stock levels, balancing the increased cost of holding larger onshore inventories against the risk of recurrent tariff disruption. Additionally, capital allocation has shifted to support dual-sourcing initiatives, signing long-term offtake agreements with regional glass manufacturers, and investing in local converting capacity where feasible. These measures have aimed to shorten lead times and protect critical programs from sudden cost escalations.

From a regulatory and compliance perspective, the need to qualify alternative sources has required cross-functional alignment across quality, regulatory affairs, and supply chain teams to ensure new suppliers meet established chemical and particulate specifications without introducing undue program risk. Ultimately, the tariff environment in 2025 has reinforced the importance of integrated sourcing strategies that combine cost management with technical qualification, operational agility, and contractual mechanisms that share risk between buyers and suppliers.

Deep segmentation analysis connecting container types, glass classifications, therapeutic end uses, closure technologies, and distribution channels to practical packaging decisions

A robust segmentation framework highlights how product form, material composition, end-use application, closure design, and distribution pathway each shape technical requirements and commercial priorities for pharmaceutical glass packaging. Container type drives primary performance criteria: ampoules are selected for single-dose, contamination-minimizing applications; bottles serve oral liquid and topical formulations and therefore emphasize inertness and compatibility with dosing mechanisms; cartridges are specified in safety and standard variants depending on device interfacing and pressure tolerances; prefilled syringes prioritize precision filling and delivery performance; and vials are produced for either multi-dose or single-dose use, with multi-dose containers requiring particular attention to stopper chemistry and preservative interactions.

Glass type further informs decision-making, with Type I formulations typically favored for high-stability biologics due to superior hydrolytic resistance, while Type II and Type III glass may be specified where processing economics or specific regulatory pathways allow. End use categories such as biotech products, injectable drugs, ophthalmic products, oral drugs, and vaccines impose unique regulatory and functional constraints that cascade into container and closure selection, sterilization approaches, and extractables/leachables testing regimes. Closure type intersects with container choice to govern container closure integrity and compatibility: crimp caps offer established sterility assurance for parenteral vials, rubber stoppers provide essential sealing functions with variants like bromobutyl and chlorobutyl chosen based on elastomeric compatibility and permeability profiles, screw caps and snap caps serve oral and topical formats where resealability and user ergonomics matter.

Distribution channels also shape packaging priorities; hospital pharmacies demand robustness for high-volume, sterile handling environments, online pharmacy channels emphasize secure tamper-evident solutions and ambient stability during logistics, and retail pharmacy formats must balance shelf appeal with durability and ease of dispensing. Integrating these segmentation dimensions enables a nuanced view of product specifications, supplier capabilities, and quality control measures that together determine the suitability of particular glass and closure combinations for each therapeutic and distribution context.

Regional strategic imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine sourcing, compliance, and capacity expansion priorities

Regional dynamics continue to exert a decisive influence on sourcing, regulatory alignment, and capacity expansion decisions across the pharmaceutical glass packaging value chain. In the Americas, manufacturers benefit from proximity to large pharmaceutical hubs and an emphasis on regulatory compliance that prioritizes rapid qualification, but they also face pressures to localize supply and reduce tariff exposure. This has encouraged investments in onshore converting capacity and deeper supplier partnerships to ensure continuity for high-value biologic programs.

Europe, Middle East & Africa present a heterogeneous landscape where advanced glass manufacturing capacities coexist with evolving regulatory harmonization efforts. European producers are often at the forefront of innovation in low-alkali borosilicate and energy-efficient furnace technologies, and regional regulatory frameworks emphasize stringent extractables and leachables evaluation, driving early supplier engagement and rigorous documentation practices. Meanwhile, markets in the Middle East and Africa are increasingly important as distribution nodes and as potential sites for regional manufacturing expansions that address local demand growth.

Asia-Pacific remains a major locus for both primary glass production and converting activities, with manufacturers in the region scaling capacity to serve global supply chains. The region's manufacturing depth and cost competitiveness make it a key strategic source, but quality expectations and regulatory alignment require sustained supplier development and robust auditing programs. Across all regions, the interplay of capacity, regulatory expectations, and geopolitical considerations requires companies to develop differentiated regional strategies that blend local sourcing with validated global backstops.

How leading suppliers combine high-purity glass technologies, integrated quality systems, strategic acquisitions, and collaborative partnerships to meet evolving pharmaceutical needs

Leading companies in the pharmaceutical glass packaging space are distinguishing themselves through investments in high-purity glass formulations, integrated quality systems, and collaborative partnerships that extend beyond transactional supply. Strategic players are deploying advanced analytics to monitor production consistency, leveraging in-line inspection technologies to reduce defect rates, and investing in low-emissions furnace technologies to address both operational efficiency and sustainability goals. In parallel, some suppliers are expanding their service offerings to include regulatory dossier support, stability testing collaborations, and joint development agreements with drug developers to accelerate time-to-market and to de-risk novel container closure configurations.

Competitive dynamics also reflect consolidation in certain segments, with larger manufacturers pursuing capacity expansions and strategic acquisitions to secure scale for high-demand formats such as vials and prefilled syringes. At the same time, nimble specialty firms focus on niche capabilities-such as high-performance stopper formulations or advanced glass coatings-that address specific technical failure modes. The result is a bifurcated supplier landscape where scale and specialization coexist, compelling pharmaceutical companies to adopt sophisticated supplier segmentation strategies based on technical fit, capacity reliability, and long-term innovation roadmaps.

Finally, cross-sector collaboration with device manufacturers, elastomer producers, and analytical laboratories has become more prevalent as companies seek to validate integrated container closure systems under real-world use conditions. Such partnerships reduce qualification timelines and improve the predictability of product performance across launch and lifecycle phases.

Practical and replicable actions for manufacturers to strengthen supplier diversification, validate container closure performance, and integrate sustainability without compromising product integrity

Industry leaders should adopt a multi-pronged approach that aligns technical validation, sourcing resilience, and sustainability to protect product integrity while maintaining commercial flexibility. Begin by instituting dual-sourcing strategies for critical formats and materials, paired with expedited supplier qualification pathways that emphasize analytical comparability for extractables and leachables, container closure integrity, and particulate profiles. These measures reduce single-source exposure and provide operational options when geopolitical or tariff-related disruptions occur.

Concurrently, integrate lifecycle thinking into packaging decisions by assessing recyclability, furnace energy intensity, and opportunities to incorporate recycled cullet where compatible with drug stability requirements. Transition plans should be phased and validated through stability and compatibility studies to avoid unintended quality risks. Moreover, prioritize long-term partnerships with suppliers that offer co-development capabilities, regulatory dossier support, and capacity expansion commitments tied to mutually agreed performance metrics.

Operationally, invest in advanced inspection and traceability systems to enhance lot-level control and to expedite root-cause analyses when deviations occur. Engage cross-functional teams early in container and closure selection to ensure that formulation scientists, quality, supply chain, and regulatory functions align on test protocols and acceptance criteria. Finally, maintain a dynamic scenario planning cadence that models tariff shifts, raw material shortages, and demand surges so leaders can make timely, evidence-based decisions that balance technical integrity and commercial imperatives.

A transparent and validated research methodology combining expert interviews, regulatory and technical literature review, and triangulation to underpin actionable packaging intelligence

The research methodology underpinning this analysis combines qualitative and quantitative evidence streams to ensure robust, defensible conclusions and actionable recommendations. Primary data collection included structured interviews with packaging engineers, procurement leaders, regulatory affairs professionals, and quality assurance experts across manufacturers, contract packagers, and supplier firms to capture first-hand perspectives on technical challenges, sourcing dynamics, and strategic responses. These interviews were designed to surface operational constraints, supplier selection criteria, and validation practices that informed the segmentation and regional analysis.

Secondary research involved a comprehensive review of regulatory guidance documents, industry technical standards, white papers on glass formulation and closure interactions, and recent peer-reviewed literature addressing extractables and leachables, delamination, and container closure integrity testing. This background informed best-practice frameworks and provided technical baselines for comparative assessment. Data validation was performed through triangulation: claims and trends identified in interviews were cross-checked against documented regulatory positions and manufacturing capability disclosures from suppliers and industry consortia.

Limitations of the methodology include the evolving nature of tariff policies, which can change rapidly, and the variability of supplier-level disclosures on proprietary formulations and process specifications. To mitigate these limitations, sensitivity analyses and scenario-based considerations were incorporated, and respondents were selected to ensure diversity across geographies, company sizes, and functional roles. The resulting methodological approach balances depth of insight with practical validation to support strategic decision-making.

Key takeaways on aligning technical validation, supplier resilience, and sustainability to protect pharmaceutical product quality and commercial agility

In conclusion, pharmaceutical glass packaging is at a strategic inflection point where technical requirements, regulatory rigor, and supply chain dynamics converge to reshape procurement and development choices. The rise of complex biologics and injectable therapies elevates the importance of material selection, closure chemistry, and container closure integrity, necessitating earlier cross-functional alignment and deeper supplier engagement. Concurrently, tariff disruptions and geopolitical shifts have accelerated regionalization and dual-sourcing approaches, prompting organizations to rethink inventory policies and qualification pathways.

Sustainability and operational efficiency now factor directly into procurement and R&D decisions, driving investments in low-emission production, recycled content where appropriate, and circular logistics. To navigate this landscape, companies must combine disciplined technical validation with strategic supply diversification, invest in digital traceability and inspection capabilities, and cultivate long-term partnerships that support co-development and regulatory readiness. These combined efforts will enable pharmaceutical manufacturers and suppliers to protect product quality while maintaining commercial agility and regulatory compliance in an increasingly complex global environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of amber glass vials to enhance biologic drug stability under UV exposure
  • 5.2. Increasing integration of prefillable glass syringes for improved dosing accuracy and safety in biologics delivery
  • 5.3. Shift towards Type I borosilicate glass containers to meet stringent regulatory requirements for injectable drugs
  • 5.4. Growing investment in advanced glass coating technologies to reduce particulate contamination risks
  • 5.5. Surging demand for multi-dose glass vials with integrated microbial barriers for vaccine storage
  • 5.6. Adoption of smart packaging solutions embedding RFID sensors in glass containers for real-time drug tracking
  • 5.7. Development of thin-walled glass cartridges to optimize material usage and minimize carbon footprint in injectable packaging
  • 5.8. Expansion of recycling and glass remelt initiatives to support sustainable pharmaceutical packaging practices

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Glass Packaging Market, by Container Type

  • 8.1. Ampoules
  • 8.2. Bottles
    • 8.2.1. Oral Liquid
    • 8.2.2. Topical
  • 8.3. Cartridges
    • 8.3.1. Safety
    • 8.3.2. Standard
  • 8.4. Prefilled Syringe
  • 8.5. Vials
    • 8.5.1. Multi Dose
    • 8.5.2. Single Dose

9. Pharmaceutical Glass Packaging Market, by Glass Type

  • 9.1. Type I
  • 9.2. Type II
  • 9.3. Type III

10. Pharmaceutical Glass Packaging Market, by End Use

  • 10.1. Biotech Products
  • 10.2. Injectable Drugs
  • 10.3. Ophthalmic Products
  • 10.4. Oral Drugs
  • 10.5. Vaccines

11. Pharmaceutical Glass Packaging Market, by Closure Type

  • 11.1. Crimp Cap
  • 11.2. Rubber Stopper
    • 11.2.1. Bromobutyl
    • 11.2.2. Chlorobutyl
  • 11.3. Screw Cap
  • 11.4. Snap Cap

12. Pharmaceutical Glass Packaging Market, by Distribution Channel

  • 12.1. Hospital Pharmacy
  • 12.2. Online Pharmacy
  • 12.3. Retail Pharmacy

13. Pharmaceutical Glass Packaging Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pharmaceutical Glass Packaging Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pharmaceutical Glass Packaging Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Gerresheimer AG
    • 16.3.2. SGD Pharma S.A.
    • 16.3.3. SCHOTT AG
    • 16.3.4. Stevanato Group S.p.A.
    • 16.3.5. Nipro Corporation
    • 16.3.6. Ardagh Group S.A.
    • 16.3.7. Owens-Illinois, Inc.
    • 16.3.8. Piramal Glass Limited
    • 16.3.9. Temco Group Ltd.
    • 16.3.10. Universal Glass Packaging, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. PHARMACEUTICAL GLASS PACKAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. PHARMACEUTICAL GLASS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL GLASS PACKAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TOPICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TOPICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TOPICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SAFETY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SAFETY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SAFETY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SAFETY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SAFETY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SAFETY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY STANDARD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY STANDARD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY STANDARD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY STANDARD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY STANDARD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY PREFILLED SYRINGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY PREFILLED SYRINGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY PREFILLED SYRINGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY PREFILLED SYRINGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY MULTI DOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY MULTI DOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE I, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE I, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE I, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE I, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE I, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE I, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE II, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE II, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE II, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE II, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE II, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE II, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE III, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE III, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE III, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE III, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE III, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY TYPE III, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BIOTECH PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BIOTECH PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BIOTECH PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BIOTECH PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BIOTECH PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BIOTECH PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY INJECTABLE DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY INJECTABLE DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY INJECTABLE DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY INJECTABLE DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY INJECTABLE DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY INJECTABLE DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ORAL DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VACCINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VACCINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VACCINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CRIMP CAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CRIMP CAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CRIMP CAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CRIMP CAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CRIMP CAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CRIMP CAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BROMOBUTYL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BROMOBUTYL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BROMOBUTYL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BROMOBUTYL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BROMOBUTYL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BROMOBUTYL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CHLOROBUTYL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CHLOROBUTYL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CHLOROBUTYL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CHLOROBUTYL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CHLOROBUTYL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CHLOROBUTYL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SCREW CAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SCREW CAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SCREW CAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SCREW CAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SCREW CAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SCREW CAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SNAP CAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SNAP CAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SNAP CAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SNAP CAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SNAP CAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SNAP CAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CARTRIDGES, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY VIALS, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY GLASS TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY RUBBER STOPPER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST PHARMACEUTICAL GLASS PACKAGING MAR